| Ticker Symbol: | CRY |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 1655 Roberts Boulevard N.W. Kennesaw GA 30144 770 419-3355 |
| CEO/President: | Steven G. Anderson |
| Industry: | Medical Products / Standard Industry Code: 3841 |
| Description: | CryoLife, Inc. is the leader in the development and commercialization of implantable living human tissues for use in cardiovascular, vascular, and orthopaedic surgeries throughout the United States and Canada. The company\'s BioGlue surgical adhesive, the company marked in the European Union for use in vascular and pulmonary sealing and repair, is distributed throughout Europe. The company also manufactures CryoLife- O\'Brien and CryoLife-Ross stentless porcine heart valves which are distributed within the European Community. (PRESS RELEASE) |
| Shares Outstanding: | 28,000 (000) | Market Value: | 281,440 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 52.95% | Number of Inst.Shareholders: | 14.00% |
| Last Quarter Sales: | 26.80 ($Mil.) | Last Quarter Net Income: | 3.56 ($Mil.) |
| Last Quarter EPS: | 0.12 | P/E Ratio: | 23 |
| Most Recent Earnings: | 0.12 on 10/30/08 | Earnings Per Share: | 0.46 |
| Most Recent Split: | 3-2 on 12/28/00 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| BOSTON SCIENTIF | -40.40 | 7.19 | |
| MEDTRONIC INC | -32.50 | 36.42 | |
| BAXTER INTL INC | -4.00 | 58.07 | |
| ZIMMER HOLDINGS | -47.30 | 39.77 | |
| ST. JUDE MEDICA | -24.30 | 31.90 |
